Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Use of melanotan I and II in the general population.

× No keyword cloud information.

5 in total

1. [Dermoscopic changes in melanocytic nevi during use of melanotan II].

Authors: R Mang; D Krahl; T Assmann
Journal: Hautarzt Date: 2012-11 Impact factor: 0.751

2. Injection site infections and injuries in men who inject image- and performance-enhancing drugs: prevalence, risks factors, and healthcare seeking.

Authors: V D Hope; J McVeigh; A Marongiu; M Evans-Brown; J Smith; A Kimergård; J V Parry; F Ncube
Journal: Epidemiol Infect Date: 2014-04-08 Impact factor: 4.434

3. Would You Use It With a Seal of Approval? Important Attributes of 2,4-Dinitrophenol (2,4-DNP) as a Hypothetical Pharmaceutical Product.

Authors: Emma E Bleasdale; Sam N Thrower; Andrea Petróczi
Journal: Front Psychiatry Date: 2018-04-20 Impact factor: 4.157

4. Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study.

Authors: Vivian D Hope; Jim McVeigh; Andrea Marongiu; Michael Evans-Brown; Josie Smith; Andreas Kimergård; Sara Croxford; Caryl M Beynon; John V Parry; Mark A Bellis; Fortune Ncube
Journal: BMJ Open Date: 2013-09-12 Impact factor: 2.692

5. Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992-2013.

Authors: Vivian D Hope; Ross Harris; Jim McVeigh; Katelyn J Cullen; Josie Smith; John V Parry; Daniela DeAngelis; Fortune Ncube
Journal: J Acquir Immune Defic Syndr Date: 2016-03-01 Impact factor: 3.731

5 in total